Subscribe to RSS
DOI: 10.1055/s-0041-1722929
Sinonasal Symptoms and Self-Reported Health before and after Endoscopic Pituitary Surgery—A Prospective Study
Funding This study was supported by grants from the Swedish state under the agreement between the Swedish government and the County Councils, the ALF agreement (ALFGBG-719531 and ALFGBG-772591), by grants from the Health & Medical Care Committee of the Region Västra Götaland, Sweden (VGFOUREG-929693), and The Swedish Society of Medicine (SLS-884901).Abstract
Objectives Despite the limited invasiveness of endoscopic transsphenoidal surgery (ETSS), some degree of nasal structure destruction is unavoidable. Our objective was to evaluate sinonasal morbidity and self-reported health before and 6 months after ETSS for pituitary tumors, and to identify possible predictive factors for deterioration in sinonasal health.
Design Prospective observational cohort study.
Setting University tertiary referral hospital.
Participants Totally 109 consecutive adult patients undergoing ETSS for pituitary tumors between 2015 and 2019.
Main Outcome Measures Sinonasal symptoms and self-reported health before and 6 months after ETSS, assessed by the Sinonasal Outcome Test (SNOT-22) and the EQ-5D questionnaire. Predictive factors for postoperative deterioration in sinonasal symptoms.
Results The overall SNOT-22 score did not change, but the score of the rhinologic domain of SNOT-22 worsened from 6.0 ± 5.9 before to 8.0 ± 7.4 6 months after surgery (p = 0.011). The EQ-5D visual analog scale improved from 64.0 ± 22.9 before to 71.1 ± 18.7 6 months after surgery (p = 0.00088). Univariate and multivariable regression analyses showed that prior sinonasal surgery was associated with a significant worsening in rhinologic symptoms 6 months after surgery (p = 0.046 and p = 0.020, respectively).
Conclusions Although self-reported overall health improved, significant deterioration of rhinologic symptoms was seen 6 months after ETSS. This information is important for preoperative patient counselling. Further refinement of the surgical technique and follow-up strategies to reduce postoperative sinonasal morbidity could be of value, especially in patients who have undergone prior sinonasal surgery.
Publication History
Received: 31 October 2020
Accepted: 02 December 2020
Article published online:
18 February 2021
© 2021. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Schloffer H. Erfolgreiche operation eines hypophysentumors auf nasalem wege. Wien Klin Wochenschr 1907; 20: 621-624
- 2 Hardy J. Transsphenoidal removal of pituitary adenomas. Union Med Can 1962; 91: 933-945
- 3 Jankowski R, Auque J, Simon C, Marchal JC, Hepner H, Wayoff M. Endoscopic pituitary tumor surgery. Laryngoscope 1992; 102 (02) 198-202
- 4 Gao Y, Zhong C, Wang Y. et al. Endoscopic versus microscopic transsphenoidal pituitary adenoma surgery: a meta-analysis. World J Surg Oncol 2014; 12: 94
- 5 Penn DL, Burke WT, Laws ER. Management of non-functioning pituitary adenomas: surgery. Pituitary 2018; 21 (02) 145-153
- 6 Molitch ME. Diagnosis and treatment of pituitary adenomas: a review. JAMA 2017; 317 (05) 516-524
- 7 Little AS, Kelly D, Milligan J. et al. Predictors of sinonasal quality of life and nasal morbidity after fully endoscopic transsphenoidal surgery. J Neurosurg 2015; 122 (06) 1458-1465
- 8 Mamelak AN. Pro: endoscopic endonasal transsphenoidal pituitary surgery is superior to microscope-based transsphenoidal surgery. Endocrine 2014; 47 (02) 409-414
- 9 Mortini P. Cons: endoscopic endonasal transsphenoidal pituitary surgery is not superior to microscopic transsphenoidal surgery for pituitary adenomas. Endocrine 2014; 47 (02) 415-420
- 10 Dallapiazza R, Bond AE, Grober Y. et al. Retrospective analysis of a concurrent series of microscopic versus endoscopic transsphenoidal surgeries for Knosp Grades 0-2 nonfunctioning pituitary macroadenomas at a single institution. J Neurosurg 2014; 121 (03) 511-517
- 11 Karppinen A, Kivipelto L, Vehkavaara S. et al. Transition from microscopic to endoscopic transsphenoidal surgery for nonfunctional pituitary adenomas. World Neurosurg 2015; 84 (01) 48-57
- 12 Yu S-Y, Du Q, Yao S-Y. et al. Outcomes of endoscopic and microscopic transsphenoidal surgery on non-functioning pituitary adenomas: a systematic review and meta-analysis. J Cell Mol Med 2018; 22 (03) 2023-2027
- 13 Rotenberg B, Tam S, Ryu WHA, Duggal N. Microscopic versus endoscopic pituitary surgery: a systematic review. Laryngoscope 2010; 120 (07) 1292-1297
- 14 Li A, Liu W, Cao P, Zheng Y, Bu Z, Zhou T. Endoscopic versus microscopic transsphenoidal surgery in the treatment of pituitary adenoma: a systematic review and meta-analysis. World Neurosurg 2017; 101: 236-246
- 15 Baudracco I, Ekanayake J, Warner E, Grieve JP, Dorward NL. Olfactory outcomes after transsphenoidal endonasal surgery. Br J Neurosurg 2020; 34 (01) 35-39
- 16 Wang S, Chen Y, Li J, Wei L, Wang R. Olfactory function and quality of life following microscopic endonasal transsphenoidal pituitary surgery. Medicine (Baltimore) 2015; 94 (04) e465
- 17 Rotenberg BW, Saunders S, Duggal N. Olfactory outcomes after endoscopic transsphenoidal pituitary surgery. Laryngoscope 2011; 121 (08) 1611-1613
- 18 Zimmer LA, Shah O, Theodosopoulos PV. Short-term quality-of-life changes after endoscopic pituitary surgery rated with SNOT-22. J Neurol Surg B Skull Base 2014; 75 (04) 288-292
- 19 McCoul ED, Anand VK, Bedrosian JC, Schwartz TH. Endoscopic skull base surgery and its impact on sinonasal-related quality of life. Int Forum Allergy Rhinol 2012; 2 (02) 174-181
- 20 Jakobsson S, Olsson DS, Andersson E. et al. Extended support within a person-centered practice after surgery for patients with pituitary tumors: protocol for a quasiexperimental study. JMIR Res Protoc 2020; 9 (07) e17697
- 21 Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP. Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol 2009; 34 (05) 447-454
- 22 Sahlstrand-Johnson P, Ohlsson B, Von Buchwald C, Jannert M, Ahlner-Elmqvist M. A multi-centre study on quality of life and absenteeism in patients with CRS referred for endoscopic surgery. Rhinology 2011; 49 (04) 420-428
- 23 Chaudhry IV S, Chaudhry S, Qureshi T, Batra PS. Evolution of sinonasal symptoms and mucosal healing after minimally invasive pituitary surgery. Am J Rhinol Allergy 2017; 31 (02) 117-121
- 24 Pledger CL, Elzoghby MA, Oldfield EH, Payne SC, Jane Jr JA. Prospective comparison of sinonasal outcomes after microscopic sublabial or endoscopic endonasal transsphenoidal surgery for nonfunctioning pituitary adenomas. J Neurosurg 2016; 125 (02) 323-333
- 25 Browne JP, Hopkins C, Slack R, Cano SJ. The Sino-Nasal Outcome Test (SNOT): can we make it more clinically meaningful?. Otolaryngol Head Neck Surg 2007; 136 (05) 736-741
- 26 Sahlstrand-Johnson P, Hopkins C, Ohlsson B, Ahlner-Elmqvist M. The effect of endoscopic sinus surgery on quality of life and absenteeism in patients with chronic rhinosinusitis - a multi-centre study. Rhinology 2017; 55 (03) 251-261
- 27 EuroQol Group. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy 1990; 16 (03) 199-208
- 28 Janssen MF, Pickard AS, Golicki D. et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res 2013; 22 (07) 1717-1727
- 29 Balaker AE, Bergsneider M, Martin NA, Wang MB. Evolution of sinonasal symptoms following endoscopic anterior skull base surgery. Skull Base 2010; 20 (04) 245-251
- 30 McCoul ED, Bedrosian JC, Akselrod O, Anand VK, Schwartz TH. Preservation of multidimensional quality of life after endoscopic pituitary adenoma resection. J Neurosurg 2015; 123 (03) 813-820
- 31 Schreiber A, Bertazzoni G, Ferrari M. et al. Nasal morbidity and quality of life after endoscopic transsphenoidal surgery: a single-center prospective study. World Neurosurg 2019; 123: e557-e565
- 32 Wu V, Cusimano MD, Lee JM. Extent of surgery in endoscopic transsphenoidal skull base approaches and the effects on sinonasal morbidity. Am J Rhinol Allergy 2018; 32 (01) 52-56
- 33 Chowdhury NI, Mace JC, Bodner TE. et al. Investigating the minimal clinically important difference for SNOT-22 symptom domains in surgically managed chronic rhinosinusitis. Int Forum Allergy Rhinol 2017; 7 (12) 1149-1155
- 34 Escada P. [Localization and distribution of human olfactory mucosa in the nasal cavities]. Acta Med Port 2013; 26 (03) 200-207
- 35 Alobid I, Enseñat J, Mariño-Sánchez F. et al. Impairment of olfaction and mucociliary clearance after expanded endonasal approach using vascularized septal flap reconstruction for skull base tumors. Neurosurgery 2013; 72 (04) 540-546
- 36 de Almeida JR, Snyderman CH, Gardner PA, Carrau RL, Vescan AD. Nasal morbidity following endoscopic skull base surgery: a prospective cohort study. Head Neck 2011; 33 (04) 547-551